New Study from the NIH Integrated Islet Distribution Program and DRCs Reveals How Human Pancreatic Islet Cell Composition Shapes Diabetes Risk

Written By Diana L Sung

SDRC member Anna Gloyn and others lead efforts mapping diabetes risk to pancreatic islet cell heterogeneity and genes that could drive variation in blood sugar regulation.

Diana L Sung
Previous

GLP-1s 101: Stanford Medicine Endocrinologist and SDRC Investigator Sun H. Kim, with Others, Weighs In on Weight Loss, Side Effects and Safety
Next

Why Ozempic May Not Work for Everyone: SDRC Investigator Anna Gloyn and Colleagues Uncover a Genetic Resistance to GLP-1 Drugs